Swiss SME developing and validating commercial diagnostic tests for plant viruses, nursery certification, and plant health surveillance.
BIOREBA AG is a Swiss SME specialising in the development and supply of diagnostic tests for plant viruses and other plant pathogens, serving plant health laboratories, certification bodies, and the nursery industry. Their commercial work centres on serological and molecular test kits for detecting viruses in fruit trees, grapevines, and agricultural crops — used by official plant health inspectors and certified nurseries across Europe. In their H2020 participation, they contributed as a technical specialist in plant diagnostic methodology, bringing commercial test-development expertise into research consortia focused on protocol validation, inter-laboratory standardisation, and next-generation sequencing applications for pest identification. Their dual role as both a test manufacturer and an active participant in international validation studies makes them a practical bridge between research-grade methodology and market-ready diagnostic products.
Both VirFree and VALITEST centre on detecting plant viruses in propagative material and agricultural crops, reflecting the core diagnostic mission present across BIOREBA's entire H2020 portfolio.
VALITEST explicitly targeted test performance studies, validated protocols, reference materials, and proficiency testing schemes for plant health diagnostics across multiple pest and pathogen categories.
VirFree focused on establishing reliable virus diagnostics for certified planting material in fruit tree and grapevine nurseries, a high-value commercial niche for phytosanitary compliance.
VALITEST listed NGS among its core keywords, indicating BIOREBA's engagement with high-throughput sequencing approaches as a complement to classical serological methods.
In their first H2020 project (VirFree, 2017), BIOREBA's focus was narrowly defined around virus diagnostics for specific, high-value crop categories — certified nursery stock of fruit trees and grapevines. By 2018, in VALITEST, the scope broadened substantially to cover a wider range of plant pests and pathogens, with strong emphasis on method validation, reference materials, proficiency testing across laboratories, and emerging molecular tools such as next-generation sequencing. The trajectory is a clear shift from crop-specific certification diagnostics toward plant health diagnostic infrastructure more broadly — standard-setting, cross-laboratory validation, and test performance methodology applicable at the regulatory level.
BIOREBA is moving into the diagnostic standards and regulatory compliance space — method validation, proficiency schemes, and reference materials — suggesting future collaboration interest in EPPO standard development, EU plant health regulation implementation, and multi-laboratory ring trials.
BIOREBA has participated exclusively as a consortium partner across both H2020 projects, never in a coordinator role, consistent with their profile as a specialist supplier contributing focused diagnostic expertise rather than a research management organisation. Despite only two projects, they engaged with 31 unique partners across 15 countries, indicating they join large, internationally distributed consortia typical of Innovation Action and MSCA-RISE programmes. A future partner should expect them to contribute as a targeted technical specialist — supplying test kits, running validation studies, or providing reference materials — rather than leading scientific workpackages or managing project administration.
BIOREBA's 31 consortium partners across 15 countries, accumulated through just two projects, reflects participation in large international networks in the plant health and agricultural research space. Their network almost certainly spans national plant health reference laboratories, university research groups, and certification bodies across the EU and associated countries.
BIOREBA occupies a rare position as a commercial diagnostic test manufacturer that actively participates in EU-funded research to validate and standardise the very methods underlying their product line — a combination that gives them credibility with official plant health bodies that purely academic partners cannot match. For a consortium building a project around plant disease surveillance, regulatory compliance, or diagnostic method harmonisation, BIOREBA brings both scientific engagement and direct market translation. Their Swiss base also makes them a practical partner for consortia seeking non-EU associated country involvement.
